board of directors

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The investment firm had sought to place two candidates on Enzo's board but withdrew its proxy contest after failing to gain ISS's endorsement.

The Enzo shareholder issued an open letter stating its concern about the company's stock performance.

NEW YORK (GenomeWeb) – Epic Sciences has raised $30 million in a Series C round of private financing that it will use to support development of its circulating tumor cell analysis platform.

NEW YORK (GenomeWeb News) – Vermillion said in a US Securities and Exchange Commission filing released after the close of the market yesterday that its shareholders elected Robert Goggin to the company's board of directors at the firm's annual meeting last week.

NEW YORK (GenomeWeb News) – Proxy voting advisory firm Institutional Shareholder Services has recommended that Vermillion shareholders elect dissident shareholder Robert Goggin to the Austin, Texas-based company's board.

NEW YORK (GenomeWeb News) – Nanosphere reported after the close of the market Wednesday that its full-year revenues more than doubled and it trimmed its annual loss.

NEW YORK (GenomeWeb News) – A day after its chairman's re-election was blocked and its CEO resigned, Genetic Technologies named a new chairman and acting CEO today.

NEW YORK (GenomeWeb News) – Paul MacLeman, CEO of Australian firm Genetic Technologies, and other members of the firm's board and executive team resigned Tuesday following the firm's annual general meeting.

NEW YORK (GenomeWeb News) – Pressure BioSciences today said that it has reached an agreement with investors on the first half of a targeted $1.2 million private placement.

Pages

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.